Fig. 1From: Survival outcomes of patients with concomitant acute variceal bleeding and acute coronary syndrome, and the role of antiplatelet agents: an institutional experience from a lower middle-income CountryIncidence of Acute variceal bleeding (AVB) and Acute coronary events on follow up. One patient in the group without antiplatelet use developed recurrent AVB on day 10. Two patients with antiplatelet use developed acute coronary event; one at day 20, and other at day 150, on mean follow up of 180 daysBack to article page